Abstract
Kidney transplantation was first performed in Japan in 1956. Liver, heart, and pancreas transplantation began in 1964, 1968, and 1984, respectively. From 1964 until the end of 1987, 5328 kidney transplantations were performed in 122 facilities. A total of 75.7% of the grafts came from living related donors and 24.3% from cadavers. Although there were 80553 patients on dialysis at the end of 1987, only 572 renal transplants were performed that year. No liver or heart transplantations have been performed since 1968. In this review, data from the Japanese National Registry on Dialysis and Transplantation are presented. In addition, the social problems and public attitude towards brain death legislation and organ transplantation are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Collier DSJ, Calne R, Thiru S, Friend PJ, Lim S, White DJG, Kohno H, Levickis J (1987) FK-506 in experimental renal allografts. Transplant Proc 19:3975–3977
Dickneite G, Schorlemmer HU, Walter P, Sedlacek HH (1986) Graft survival in experimental transplantation could be prolonged by the action of the antitumoral drug. Transplant Proc 18:1295–1296
Inou T, Kusaba R, Takahashi I, Sugimoto H, Kuzahara K, Yamada Y, Yamauchi J, Otsubo O (1981) Clinical trial of bredinin in renal transplantation. Transplant Proc 13:315–318
Japan Society for Transplantation (1988) Kidney transplantation registry (1987) Jpn J Transplant 23:315–333
Kincaid-Smith P (1969) Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants. Lancet II:920–922
Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H, Ochiai T (1987) FK-506, a novel immunosuppressant isolated from aStreptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 40:1256–1265
Ochiai T, Nakajima K, Nagata N, Suzuki T, Asano T, Uematsu T, Goto T, Hori S, Kenmochi T, Nakagoori T, Isono K (1987) Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. Transplant Proc 19:1284–1286
Odaka M (1989) Present status of dialysis therapy in Japan (1988) J Jpn Soc Dial Ther 22:1–39
Sakaguchi K, Tsujino M, Yoshizawa M, Mizuno K, Hayano K (1975) Action of bredinin on mammalian cells. Cancer Res 35:1643–1648
Suzuki S, Kanashiro M, Watanabe H, Amemiya H (1988) The therapeutic effect of 15-deoxyspergualin on acute graft rejection detected by P nuclear magnetic resonance spectrography, and its effect on rat heart transplantation. Transplantation 46: 669–672
Teraoka S, Oba S, Takahashi K, Yagisawa T, Yamaguchi Y, Sanaka T, Tanabe K, Kawai T, Fuchinoue S, Honda H, Yasuo M, Hayasaka Y, Toma H, Agishi T, Ota K (1987) Therapeutic effect of antiplatelet agents on obstructive vascular lesions after kidney transplantation with cyclosporine. Transplant Proc 19:77–81
Todo S, Ueda Y, Demetris JA, Imventarza O, Nalesnik M, Venkataramanan R, Makowka L, Starzl TE (1988) Immuno-suppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery 104:239–249
Uchida H, Yokota K, Akiyama N, Masaki Y, Aso K, Okubo M, Okudaira M, Kato M, Kashiwagi N (1979) Effectiveness of a new drug, bredinin, on canine kidney allotransplant survival. Transplant Proc 11:865–870
Voss BL, Hamilton KK, Samara ENS, McKee PA (1988) Cyclosporine suppression of endothelial prostacyclin generation. Transplantation 45:793–796
Author information
Authors and Affiliations
About this article
Cite this article
Ota, K. Organ transplantation in Japan — present status and problems. Transplant Int 2, 61–67 (1989). https://doi.org/10.1007/BF02459321
Issue Date:
DOI: https://doi.org/10.1007/BF02459321